ArticleBMJ open diabetes research & care2020

Lipopolysaccharide-binding protein is a distinctive biomarker of abnormal pain threshold in the general Japanese population.

Kazuhiro Kudoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.